Ftse Mib
33.609,85
0,00%
DAX
18.265,68
-2,03%
S&P 500
5.433,74
0,23%
NASDAQ
17.667,56
0,34%
Bitcoin
67.049,84
0,44%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tonix Pharmaceuticals Holding Corporation (TNXP) Tonix Pharmaceuticals Holding Corporation (TNXP) Notizie

Tonix Pharmaceuticals Holding Corporation

TNXP
1,26
0,15 (13,51%)
14 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
13/6/202423:24EDGAR2Form 8-K - Current report
13/6/202423:00GLOBETonix Pharmaceuticals Announces Closing of $4.0 Million..
12/6/202423:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/6/202415:00GLOBETonix Pharmaceuticals Announces Pricing of $4.0 Million..
11/6/202423:17GLOBETonix Pharmaceuticals Announces Proposed Public Offering
11/6/202422:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/6/202414:53EDGAR2Form 8-K - Current report
06/6/202417:21EDGAR2Form 8-K - Current report
06/6/202417:00GLOBETonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
06/6/202414:05EDGAR2Form 8-K - Current report
06/6/202414:00GLOBETonix Pharmaceuticals Announces Two Oral Presentations and..
05/6/202414:00GLOBETonix Pharmaceuticals Announces Poster Presentation at the..
03/6/202414:05EDGAR2Form 8-K - Current report
03/6/202414:00GLOBETonix Pharmaceuticals Presented New Data on Tonmya™..
30/5/202414:05EDGAR2Form 8-K - Current report
30/5/202414:00GLOBETonix Pharmaceuticals Announces Two Poster Presentations of..
29/5/202414:00GLOBETonix Pharmaceuticals Announces Two Oral Presentations and..
28/5/202414:00GLOBETonix Pharmaceuticals Announces Presentation at the 2024 BIO..
24/5/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202423:16EDGAR2Form 8-K - Current report
22/5/202414:05EDGAR2Form 8-K - Current report
22/5/202414:00GLOBETonix Pharmaceuticals to Deliver an Oral Presentation and..
21/5/202414:07EDGAR2Form 8-K - Current report
21/5/202414:00GLOBETonix Pharmaceuticals Announces Key Findings from Initial..
15/5/202414:00GLOBETonix Pharmaceuticals to Present at the Alliance Global..
13/5/202422:56EDGAR2Form 8-K - Current report
13/5/202422:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:30GLOBETonix Pharmaceuticals Reports First Quarter 2024 Financial..
24/4/202414:00GLOBETonix Pharmaceuticals Announces Presentation at Planet..
01/4/202422:15GLOBETonix Pharmaceuticals Reports Fourth Quarter and Full Year..
28/3/202414:32GLOBETonix Pharmaceuticals Announces Pricing of $4.4 Million..
25/3/202413:00GLOBETonix Pharmaceuticals Receives Rare Pediatric Disease..
21/3/202413:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
20/3/202413:00GLOBETonix Pharmaceuticals Announces Selection of Two Contract..
19/3/202413:00GLOBETonix Pharmaceuticals Announces Transition to Fully..
12/3/202413:00GLOBETonix Pharmaceuticals Announces Presentation at BIO-Europe..
11/3/202413:05EDGAR2Form 8-K - Current report
11/3/202413:00GLOBETonix Pharmaceuticals Reports Improvement in “Brain Fog,” in..
07/3/202415:37GLOBENew to The Street Announces TV Episode 560 with its Five..
07/3/202414:06EDGAR2Form 8-K - Current report
07/3/202414:00GLOBETonix Pharmaceuticals Announces Publication in Psychiatry..
06/3/202423:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06/3/202414:05EDGAR2Form 8-K - Current report
06/3/202414:00GLOBETonix Pharmaceuticals Selects EVERSANA® to Support Launch..
05/3/202414:05EDGAR2Form 8-K - Current report
05/3/202414:00GLOBETonix Pharmaceuticals Announces Translation of Preclinical..
29/2/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,14 Min: 1,08 Max: 1,15
Chiusura: 1,11

La tua Cronologia

NASDAQ
TNXP
Tonix Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network